3.5.5 5-HT2R Activation Causes mEPSC Frequency Increase
Figure 4.3.1 Paired recordings
4.4.3. Comparison with Modulation by NA
The depression observed with 5-HT and a 5-HT2R agonist reminded me of that observed with 10 µM NA observed earlier in this laboratory. Before going any further, I will present some data on how NA modulated excitatory transmitter release in these cells. In 4.4.3.1, I present data for the noradrenergic modulation of spontaneous release, and point out the mechanism(s) involved. In 4.4.3.2, I present data on how NA modulated evoked release. The mechanism involved in the EPSC depression will be provided in 4.4.3.3. Note that most of the data in sections 4.4.3.1 and 4.4.3.2 was acquired by Drs. Julian
crucial data as to the molecular mechanism in 4.4.3.3. Some of these data will appear in joint publications (Choy et al., 2017a;; Choy et al., 2017b).
4.4.3.1. Involvement of Store Release in NA-Mediated mEPSC Frequency Increase Any receptor that is capable of activating the classical Gq cascade, may release Ca2+ from stores to modulate transmitter release. Some potential candidates, such as the group I metabotropic glutamate receptors (Simkus & Stricker, 2002a) and α1-AR were investigated in this laboratory. The impact of α1-AR activation on spontaneous release is shown in Fig. 4.4.15. In A, the individual mEPSC frequencies during the control period (blue bar) and after addition of 10 µM NA (red bar) are presented. The average mEPSC frequency during control was 39 ± 1 Hz, and the amplitude -13.0 ± 0.1 pA. After addition of NA at t = 0, and the resumption of the recording after another 5 min, the average mEPSC frequency increased by 34 ± 3% to 53 ± 1 Hz (A, D). Minute averages of the mEPSC frequency were normalised to the average value during control, and are shown in B. Note that, in contrast to the case with 5-HT, the mEPSC frequency increase persisted for the whole period after addition of NA. The mEPSC amplitude remained unchanged (-13.0 ± 0.1 pA;; C), not significantly different from control (E). When the average time courses of mEPSCs were superimposed (F) there was no significant change by NA.
When all such experiments were analysed (n = 49), it was found that 24 (49%) pyramidal cells showed a sustained increase in the mEPSC frequency as described above. Like in Part 3, these cells were referred to as responders. On average, NA increased the mEPSC frequency by 56 ± 7% from 39 ± 2 to 59 ± 3 Hz (ppt < 10-8;; Fig. G) in these responders. This increase persisted throughout the recording. The rest did not show any significant increase in the mEPSC frequency (non-responders). A significantly smaller mEPSC frequency during the control period was observed in responders than non- responders (39 ± 2 vs. 53 ± 4 Hz;; pt < 10-3). In addition, the NA and agonists caused a significant decrease of Rin only in responders (9 ± 7% from 122 ± 8 to 103 ± 7 MΩ;; ppt = 0.01).
The mechanisms causing the increase in mEPSC frequency were identified as follows (Choy et al., 2017a). 1) NA acted via ɑ1-ARs, which in turn 2) activated PLCβ, resulting in 3) PIP2 hydrolysis to produce IP3 and DAG. 4) The former bound to IP3R on presynaptic stores to cause 5) Ca2+ release from stores, which then 6) drove vesicle fusion, observed as an increase in mEPSC frequency.
Figure 4.4.15. NA increased the mEPSC persistently.
A. Individual instantaneous mEPSC frequencies in a single pyramidal cell shown during control (t < 0 min), and after addition of NA (t ≥ 0 min). B. Minute averages of the data in A after normalising the average control value to 0%, including the respective error bars which were smaller than the diameter of the dots. Dashed line indicates no change. C. Same as in B, but for the mEPSC amplitude. D. cPDFs of the instantaneous frequencies during control and after NA. E. Same as in F, but for the mEPSC amplitude. F. Superposition of the average mEPSC time courses during control and in NA. G. Minute averages of the pooled mEPSC frequency change in responders, after normalising as in B.
Consequently, in regard to spontaneous transmitter release, both NA and 5-HT 1) increased the mEPSC frequency without affecting its amplitude. 2) The increase in mEPSC frequency was restricted to a subset of pyramidal cells (responders). 3) Both agonists signalled via a classical Gq cascade to increase the mEPSC frequency via
presynaptic Ca2+ release from stores. However, in contrast to NA, the increase in mEPSC frequency by 5-HT was transient, but become maintained after PKC was blocked. The impact of NA on evoked transmitter release, and how it compared with 5- HT, will be presented next.
4.4.3.2. EPSCs Depression by NA
Different from what was expected from its impact on spontaneous release, NA also depressed evoked glutamate release in this layer.
The results obtained in a paired-recording after exposure to 10 µM NA is illustrated in Fig. 4.4.16. In A, the time course of the presynaptic AP (top) with the evoked average EPSC (bottom) during control is presented. The average peak EPSC amplitude was - 47.2 ± 1.2 pA. Addition of NA depressed the EPSC amplitude by 71 ± 5% to -13.7 ± 0.9 pA (B). Individual peak amplitudes during control and after NA are plotted in C. It shows that NA caused a persisting depression within 5 min of exposure. The time courses of the respective EPSCs are given in D, with the traces superimposed (left) and peak- scaled for comparison (right).
Seven such experiments are presented in E, where the paired values of the amplitudes in control and NA for the respective pairs are joined by a grey line. The average EPSC amplitude during control was -24.0 ± 5.6 pA, but depressed by 62 ± 7% to -8.3 ± 2.0 pA (ppt = 0.01) after addition of NA. Even though this depression was strictly not larger than the one caused by 5-HT, it was close to significant (62 ± 7 vs. 49 ± 3%;; pt = 0.06). The depression by NA was caused by ɑ1-AR activation (Choy et al., 2017b). Specifically, application of the ɑ1-AR agonist cirazoline (5 µM) caused a constant EPSC depression by 54 ± 18% from -8.2 ± 1.5 to -3.1 ± 0.3 pA (n = 4;; ppt < 0.05). Compared to NA, the extent of the depression caused by the ɑ1-AR agonist was indistinguishable (pt = 0.40). This depression persisted in the presence of ɑ2- and β-AR blockers yohimbine and propranolol, respectively (1 µM in both cases;; n = 5), further strengthening the idea that ɑ1-AR caused this depression. It is also important to add that in all cases tested PPR was not significantly altered (ppt = 0.37).
Comparing the impacts of NA on transmitter release with those of 5-HT, the following observations can be made: 1) Both, NA and 5-HT considerably depressed the EPSC amplitude, but increased spontaneous transmitter release. 2) Both, the depression and the increase in m EPSC frequency were downstream of a Gq-linked signalling cascade. 3) In both cases, despite a large EPSC depression, on average PPR was not altered.